UK markets closed

PureTech Health plc (PRTC)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
28.50+0.62 (+2.24%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 736.07M
Enterprise value 434.27M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.05k
Price/book (mrq)1.66
Enterprise value/revenue 579.03
Enterprise value/EBITDA -24.56

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 310.68%
S&P500 52-week change 322.36%
52-week high 334.00
52-week low 317.08
50-day moving average 326.67
200-day moving average 324.41

Share statistics

Avg vol (3-month) 33.04k
Avg vol (10-day) 3190
Shares outstanding 527M
Implied shares outstanding 627.39M
Float 8151.22M
% held by insiders 10.00%
% held by institutions 10.04%
Shares short (15 Apr 2024) 45.13k
Short ratio (15 Apr 2024) 41.36
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.02%
Shares short (prior month 15 Mar 2024) 44.17k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-38,910.00%

Management effectiveness

Return on assets (ttm)-13.09%
Return on equity (ttm)-13.25%

Income statement

Revenue (ttm)3.33M
Revenue per share (ttm)0.12
Quarterly revenue growth (yoy)-97.90%
Gross profit (ttm)N/A
EBITDA -143.25M
Net income avi to common (ttm)-65.7M
Diluted EPS (ttm)-2.40
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)327.14M
Total cash per share (mrq)1.21
Total debt (mrq)135.5M
Total debt/equity (mrq)29.57%
Current ratio (mrq)6.76
Book value per share (mrq)1.71

Cash flow statement

Operating cash flow (ttm)-105.92M
Levered free cash flow (ttm)-114.8M